---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-018074"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2023-05-05T23:59:59+00:00"
generated_at: "2026-06-15T17:24:01.702163+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ginkgo Bioworks appoints Steven Coen as Chief Accounting Officer; Marie Fallon resigns

## Summary
- Marie Fallon resigns as CAO effective May 15, 2023; she will remain through June 2 and then as consultant.
- Steven Coen appointed CAO effective same date, with annual base salary of $400,000 and $1.5M equity grant vesting over 4 years.
- Coen brings over 30 years experience, most recently Corporate VP & Controller at Charles River Laboratories (annual revenues ~$4B).
- Fallon's resignation is personal, not due to any disagreement with the company.

## SEC filing metadata
- accession: 0000950170-23-018074
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2023-05-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/0000950170-23-018074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/dna-20230501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-018074
- JSON: https://secwatch.observer/filing/0000950170-23-018074.json
- Plain text: https://secwatch.observer/filing/0000950170-23-018074.txt

## Key facts
- Executive change
  Marie E. Fallon resigned as Chief Accounting Officer at Ginkgo Bioworks Holdings, Inc..
  - Action: resigned
  - Role: Chief Accounting Officer
  source text: Marie E. Fallon informed Ginkgo Bioworks Holdings, Inc. (the “Company”) on May 1, 2023 of her intent to resign from her role as Chief Accounting Officer of the Company, effective May 15, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/0000950170-23-018074-index.htm
- Executive change
  Steven P. Coen was appointed as Chief Accounting Officer at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Chief Accounting Officer
  source text: In connection with Ms. Fallon’s resignation and subject to the approval of the Company’s Board of Directors, on May 5, 2023, the Company appointed Steven P. Coen, age 57, as its Chief Accounting Officer, effective May 15, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000095017023018074/0000950170-23-018074-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.